On the recordMay 4, 2021
Far less than in the United States Congresswoman. The typical comparison country in H.R. 3 has at most 60 percent of the brand name drugs that American consumers enjoy.
Source
congress.govFar less than in the United States Congresswoman. The typical comparison country in H.R. 3 has at most 60 percent of the brand name drugs that American consumers enjoy.
Miller discusses international drug access compared to the U.S. under H.R. 3.
Share
More from Max Miller
I hear from constituents about their frustration and even fear about this Administration's inability to negotiate new trade agreements.
So, farmers in my district are concerned about the EPA's overreach and how it impacts their ability to farm.
we need help in the de minimis environment, and there are several packages out there that will allow us to have the appropriate data.